MODIFIZIERTE ADENOVIREN

Patent europeic · EP3737403 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3737403
Numer da la dumonda
EP19711157
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
13-02-2019
Publitgà
18-11-2020
Concedì
03-01-2024
La protecziun finescha il pli tard
12-02-2039
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
A61K 38/16 (2006.01)
A61K 38/48 (2006.01)
C07K 14/005 (2006.01)
C12N 7/00 (2006.01)
Prioritad
GB 201802539 16.02.2018
Dumonda PCT
PCT/GB2019/050380 13.02.2019
Publicaziun PCT
WO2019/158914 22.08.2019
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 01-03-2025

    Midada

    Published in Swissreg on 01.03.2025

  3. 13-11-2024

    Midada

    Published in Swissreg on 13.11.2024

  4. 08-08-2024

    Licenza inscritta

    License holder
    Trocept Therapeutics Limited, Lashford House Chu rch Lane, Dry Sandford, A bingdon, Oxford OX13 6JP, United Kingdom

    Published in Swissreg on 08.08.2024

  5. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  6. 10-01-2024

    Represchentant inscrit

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 10.01.2024

  7. 03-01-2024

    Concedì

    Published in Swissreg on 03.01.2024

Partidas

Inventur

PARKER, Alan

Cowbridge, South Glamorgan CF71 7LJ, GB

UUSI-KERTTULA, Hanni

00100 Helsinki, FI

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.